Events & Presentations

Investors

Events & Presentations

Upcoming Events
Date Event Details Remind Me
Feb 4, 2021 4:30 PM EST
Arrowhead Pharmaceuticals 2021 First Quarter Results
Archived Events
Date Event Details
Sep 16, 2019
Developing Alpha-1 Antitrypsin Therapeutics; FDA Public Workshop
Bethesda, MD
Sep 14, 2019
Alpha-1 UK Support Group Event 2019
Daventry, Northamptonshire, UK
Sep 5, 2019
Citi’s 14th Annual Biotech Conference
Boston, MA
Sep 4, 2019 9:40 AM EDT
Baird's 2019 Global Healthcare Conference
New York, NY
Aug 12, 2019
BTIG Biotechnology Conference 2019
New York, NY
Aug 5, 2019 4:30 PM EDT
Arrowhead Pharmaceuticals 2019 Third Quarter Results
Jul 17, 2019
Roth RNA Revolution Conference
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, and Vincent Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in panel discussions.
Jun 21, 2019
Alpha-1 National Conference
Orlando, FL
James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “ARO-AAT for Liver Disease in Alpha-1 Antitrypsin Deficiency: Progress in Clinical Development”
Jun 8, 2019 2:30 PM +08
Science of HBV Cure 2019
Singapore
Bruce Give, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver an oral presentation titled, “RNAi: Pulling Us Toward Finite Therapy”
Jun 6, 2019 9:30 AM EDT
Jefferies 2019 Global Health Care Conference
New York, NY
Vincent Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in a fireside chat presentation with Maury Raycroft, Ph.D., Jefferies research analyst